<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01366469</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00046469</org_study_id>
    <secondary_id>CABG BALF</secondary_id>
    <nct_id>NCT01366469</nct_id>
  </id_info>
  <brief_title>Inflammatory Biomarkers Predict Pulmonary Outcomes in Coronary Artery Bypass Grafting</brief_title>
  <acronym>CABG BALF</acronym>
  <official_title>Inflammatory Biomarkers Predict Pulmonary Outcomes in Coronary Artery Bypass Grafting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this pilot study is to identify and quantify inflammatory and&#xD;
      genetic markers from bronchoalveolar lavage fluid (BALF) and serum in patients with a history&#xD;
      of chronic obstructive pulmonary disease (COPD) undergoing elective coronary&#xD;
      revascularization (CABG) to determine the risk of developing post operative respiratory&#xD;
      failure. To achieve this objective, this proposal outlines the following specific aims:&#xD;
&#xD;
      Aim #1. To identify from BALF and serum, the change in inflammatory and genetic markers in&#xD;
      patients with a history of COPD undergoing CABG. BALF and serum samples will be obtained at&#xD;
      the time of intubation immediately prior to surgery and again upon skin closure immediately&#xD;
      after the surgical procedure.&#xD;
&#xD;
      Aim #2. To determine the extent to which inflammatory and/or genetic markers correlate with&#xD;
      post-operative pulmonary complications defined as prolonged mechanical ventilation (&gt; 24&#xD;
      hours), pneumonia, and/or tracheostomy.&#xD;
&#xD;
      Aim #3. To inform the development and implementation of a large pivotal trial which may&#xD;
      impact clinical decision-making during the initial pre-operative outpatient assessment of&#xD;
      COPD patients undergoing CABG.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary outcome measure</measure>
    <time_frame>During Hospitalization</time_frame>
    <description>The identification of specific inflammatory and genetic markers associated with post-operative pulmonary complications in this population of elective CABG patients with a history of COPD.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary outcome measure</measure>
    <time_frame>30 Day Follow-up</time_frame>
    <description>Post-operative pulmonary complications: prolonged mechanical ventilation (defined as &gt;24 hours), atelectasis, pneumonia, exacerbation of COPD and tracheostomy. All-cause mortality will also be assessed.</description>
  </secondary_outcome>
  <enrollment type="Actual">10</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      BAL fluid, Serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients from Cardiothoracic surgery service&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Undergoing elective CABG&#xD;
&#xD;
          -  Current diagnosis of COPD&#xD;
&#xD;
          -  Ability to provide signed informed consent to participate&#xD;
&#xD;
          -  &gt; 18 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Concomitant valve surgery&#xD;
&#xD;
          -  Urgent or emergent coronary surgery&#xD;
&#xD;
          -  Current steroid therapy&#xD;
&#xD;
          -  Active smoker and/or positive urine co-nicotine&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omar M Lattouf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emory University Hospital Midtown</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <study_first_submitted>June 2, 2011</study_first_submitted>
  <study_first_submitted_qc>June 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2011</study_first_posted>
  <last_update_submitted>February 18, 2014</last_update_submitted>
  <last_update_submitted_qc>February 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Omar Lattouf</investigator_full_name>
    <investigator_title>Professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>coronary artery bypass grafting</keyword>
  <keyword>coronary artery disease</keyword>
  <keyword>chronic obstructive pulmonary disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

